Italy Recombinant Proteins Market Size & Outlook, 2026-2033
The recombinant proteins market in Italy is expected to reach a projected revenue of US$ 218.8 million by 2033. A compound annual growth rate of 6.5% is expected of Italy recombinant proteins market from 2026 to 2033.
- Biotechnology
- Proteomics & Protein Analysis
- Recombinant Proteins Market Outlook
- Proteomics & Protein Analysis
Revenue, 2025 (US$M)
$126.8
Estimate, 2026 (US$M)
$141.0
Forecast, 2033 (US$M)
$218.8
CAGR, 2026 - 2033
6.5%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the recombinant proteins market
Every figure cited from GVR research
Italy recombinant proteins market highlights
- The Italy recombinant proteins market generated a revenue of USD 126.8 million in 2025 and is expected to reach USD 218.8 million by 2033.
- The Italy market is expected to grow at a CAGR of 6.5% from 2026 to 2033.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2025.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Recombinant proteins market data book summary
| Market revenue in 2025 | USD 126.8 million |
| Market revenue in 2033 | USD 218.8 million |
| Growth rate | 6.5% (CAGR from 2026 to 2033) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immune checkpoint proteins, Cytokines & Growth Factors, Virus Antigens, Recombinant Regulatory Protein, Antibodies, Enzymes, Hormones |
| Key market players worldwide | Abcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Italy accounted for 3.7% of the global recombinant proteins market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK recombinant proteins market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 434.9 million by 2033.
No credit card required*
Publish Date: Jun 11, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Proteins Market Scope
Recombinant Proteins Market segmentation & scope
Others
Others
Recombinant Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Sino Biological | View profile | 251-500 | Beijing, Beijing, China, Asia | www.sinobiological.com |
| Genscript Biotech Corp Class H | View profile | 6,937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | www.genscript.com |
| Proteintech Group | View profile | 251-500 | Rosamond, Illinois, United States, North America | www.ptglab.com |
| Enzo Biochem Inc | View profile | 190 | 527 Madison Avenue, New York, NY, United States, 10022 | www.enzo.com |
| Abnova | View profile | 251-500 | Taipei, T'ai-pei, Taiwan, Asia | www.abnova.com/ |
Italy Recombinant Proteins Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Recombinant Proteins Market Outlook will help companies and investors design strategic landscapes.
Cytokines & Growth Factors was the largest segment with a revenue share of 27.76% in 2025.
Horizon Databook has segmented the Italy recombinant proteins market based on immune checkpoint proteins, cytokines & growth factors, virus antigens, recombinant regulatory protein, antibodies, enzymes, hormones covering the revenue growth of each sub-segment from 2021 to 2033.
- Italy Recombinant Proteins Market Product Outlook (Revenue, USD Million , 2021-2033)
- Cytokines & Growth Factors
- Antibodies
- Immune checkpoint proteins
- Virus Antigens
- Enzymes
- Recombinant Regulatory Protein
- Hormones
- Others
- Italy Recombinant Proteins Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery & Development
- Research
- Others
- Therapeutics
- Italy Recombinant Proteins Market Host Cells Outlook (Revenue, USD Million , 2021-2033)
- Mammalian Systems
- Insect Cells
- Yeast & Fungi
- Bacterial Cells
- Others
- Italy Recombinant Proteins Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Reasons to subscribe to Recombinant Proteins Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Recombinant Proteins Market Outlook databook
- Our clientele includes a mix of Recombinant Proteins Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Recombinant Proteins Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Recombinant Proteins Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Italy Recombinant Proteins Market, 2021-2033 (US$M)
Italy Product - Recombinant Proteins Market Statistics, 2025 - 2033 (US$M)
